Vicarious Surgical Inc (NYSE:RBOT) Short Interest Update

Vicarious Surgical Inc (NYSE:RBOT - Get Free Report) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 110,800 shares, an increase of 30.4% from the February 13th total of 85,000 shares. Currently, 2.1% of the shares of the company are short sold. Based on an average daily volume of 48,500 shares, the short-interest ratio is presently 2.3 days.

Analyst Ratings Changes

Separately, Piper Sandler dropped their price target on shares of Vicarious Surgical from $10.50 to $8.50 and set a "neutral" rating for the company in a research report on Tuesday.

Vicarious Surgical Stock Down 2.8 %

Shares of RBOT traded down $0.22 during midday trading on Friday, hitting $7.78. The company's stock had a trading volume of 11,622 shares, compared to its average volume of 33,032. Vicarious Surgical has a one year low of $4.27 and a one year high of $19.00. The stock has a market capitalization of $45.96 million, a price-to-earnings ratio of -0.76 and a beta of 1.35. The company's fifty day simple moving average is $12.30 and its two-hundred day simple moving average is $10.56.

Vicarious Surgical (NYSE:RBOT - Get Free Report) last released its earnings results on Monday, March 17th. The company reported ($2.43) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.69) by $0.26. The business had revenue of $2.09 million during the quarter. During the same quarter in the previous year, the company posted ($2.25) EPS. On average, research analysts predict that Vicarious Surgical will post -10.89 earnings per share for the current year.

Remove Ads

Hedge Funds Weigh In On Vicarious Surgical

Institutional investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC grew its stake in shares of Vicarious Surgical by 11.6% during the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company's stock worth $152,000 after buying an additional 1,200 shares during the last quarter. DnB Asset Management AS boosted its holdings in shares of Vicarious Surgical by 21.1% during the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company's stock valued at $279,000 after acquiring an additional 3,692 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in Vicarious Surgical by 8.2% during the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company's stock worth $405,000 after acquiring an additional 2,336 shares during the last quarter. 47.27% of the stock is currently owned by institutional investors and hedge funds.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.